Abstract
Background: Despite improved survival in esophageal atresia with or without tracheoesophageal fistula (EA/TEF), complications remain common. We evaluated surgical outcomes at our institution over time and compared them to published benchmarks.
Methods: We performed a retrospective single-center review of patients with EA/TEF treated between 2008 and 2023, comparing outcomes to a prior institutional cohort from 1975 to 1995. Patients were identified using ICD and CPT codes.
Results: A total of 132 patients were included across both cohorts. Patient characteristics were similar between groups. Operative repair increased from 84% to 100% (p = 0.001). Stricture (40% vs. 37%) and TEF recurrence (7% vs. 10%) rates remained stable and comparable to benchmarks. Leak rate decreased from 19% to 12%, lower than benchmark reports. Overall mortality dropped significantly from 22% to 6% (p = 0.012). Among high-risk Waterston C infants, survival improved markedly from 38% to 79% (p = 0.015).
Conclusion: EA/TEF survival has significantly improved, especially among high-risk infants with low birth weight and cardiac disease. While stricture and recurrence rates remain unchanged, leak rates have improved. These findings reflect evolving surgical practices and improved neonatal care.
